Nephros, Inc. (NEPH)

Market Cap	39.94M +79.9%
Revenue (ttm)	19.12M +23.2%
Net Income	776,000 -3.1%
EPS	0.07 -6.5%
Shares Out	10.86M
PE Ratio	51.82
Forward PE	62.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,930
Open	3.660
Previous Close	3.660
Day's Range	3.600 - 3.700
52-Week Range	2.663 - 6.420
Beta	1.47
Analysts	Buy
Price Target	7.00 (+90.28%)
Earnings Date	May 7, 2026

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 36
• Stock Exchange: NASDAQ
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Financial Performance

In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.

Analyst Summary

According to 2 analysts, the average rating for NEPH stock is "Buy." The 12-month stock price target is $7.0, which is an increase of 90.28% from the latest price.

Price Target

$7.0

(90.28% upside)

Analyst Consensus: Buy